Z

ZAGONEL V.

Last name: ZAGONEL V.

2022 (v1)

Publication

Metadata-only

PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction

Lombardi G. Spimpolo A. Berti S.

Objective: The use of regorafenib in recurrent glioblastoma patients has been recently approved by the Italian Medicines Agency (AIFA) and added to the National Comprehensive Cancer Network (NCCN) 2020 guidelines as a preferred regimen. Given its complex effects at the molecular level, the most appropriate imaging tools to assess early response...

Uploaded on: April 14, 2023
2021 (v1)

Publication

Metadata-only

Impact of gastrointestinal side effects on patients' reported quality of life trajectories after radiotherapy for prostate cancer: Data from the prospective, observational pros-it CNR study

Noale M. Bruni A. Triggiani L.

Radiotherapy (RT) represents an important therapeutic option for the treatment of localized prostate cancer. The aim of the current study is to examine trajectories in patients' reported quality of life (QoL) aspects related to bowel function and bother, considering data from the PROState cancer monitoring in ITaly from the National Research...

Uploaded on: April 14, 2023